Cost-effectiveness analysis of neoadjuvant v surgery-first for resectable pancreatic cancer

A. Bradley, R. Van Der Meer, C. McKay

Research output: Contribution to conference › Poster › peer-review

34 Downloads (Pure)

2019
Cost effectiveness analysis of the management of potentially resectable pancreatic cancer
Bradley, A., Van Der Meer, R. & McKay, C., 27 Mar 2019.
Research output: Contribution to conference › Poster › peer-review

Open Access
File
40 Downloads (Pure)
Upfront surgery versus neoadjuvant therapy for resectable pancreatic cancer: systematic review and Bayesian network meta-analysis
Bradley, A. & Van Der Meer, R., 13 Mar 2019, In: Scientific Reports. 9, 1, 7 p., 4354.
Research output: Contribution to journal › Article › peer-review

Open Access
File
39 Citations (Scopus)

31 Downloads (Pure)
2018
Markov decision analysis of neoadjuvant treatment pathway versus surgery first pathway for resectable pancreatic cancer
Bradley, A., McKay, C. J., Jamieson, N. B., Dickson, E. J., Carter, R. & Van Der Meer, R., 26 Feb 2018, In: Journal of Clinical Oncology. 36, 4 suppl, p. 456 1 p.
Research output: Contribution to journal › Conference abstract › peer-review

Open Access
File
26 Downloads (Pure)
2017

Aggregate of marginal gains: improving outcomes for pancreatic patients
Bradley, A., 27 Apr 2017.
Research output: Contribution to conference › Poster › peer-review

Research output